AU2002351730A1 - Glucagon receptor antagonists/inverse agonists - Google Patents
Glucagon receptor antagonists/inverse agonistsInfo
- Publication number
- AU2002351730A1 AU2002351730A1 AU2002351730A AU2002351730A AU2002351730A1 AU 2002351730 A1 AU2002351730 A1 AU 2002351730A1 AU 2002351730 A AU2002351730 A AU 2002351730A AU 2002351730 A AU2002351730 A AU 2002351730A AU 2002351730 A1 AU2002351730 A1 AU 2002351730A1
- Authority
- AU
- Australia
- Prior art keywords
- receptor antagonists
- glucagon receptor
- inverse agonists
- agonists
- inverse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101917 | 2001-12-19 | ||
| DKPA200101917 | 2001-12-19 | ||
| PCT/DK2002/000847 WO2003051357A1 (en) | 2001-12-19 | 2002-12-12 | Glucagon receptor antagonists/inverse agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002351730A1 true AU2002351730A1 (en) | 2003-06-30 |
Family
ID=8160913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002351730A Abandoned AU2002351730A1 (en) | 2001-12-19 | 2002-12-12 | Glucagon receptor antagonists/inverse agonists |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002351730A1 (en) |
| WO (1) | WO2003051357A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004063147A1 (en) * | 2003-01-10 | 2004-07-29 | Novo Nordisk A/S | Salts and solvates of glucagon antagonists |
| CA2513102C (en) | 2003-01-27 | 2011-03-22 | Merck & Co., Inc. | Substituted pyrazoles, compositions containing such compounds and methods of use |
| PL1756064T3 (en) | 2004-06-04 | 2008-11-28 | Merck Sharp & Dohme | Pyrazole derivatives, compositions containing such compounds and methods of use |
| CA2572745A1 (en) | 2004-07-07 | 2006-02-16 | Teresa Beeson | Pyrazole amide derivatives, compositions containing such compounds and methods of use |
| EP1773330B1 (en) | 2004-07-22 | 2010-05-26 | Merck Sharp & Dohme Corp. | Substituted pyrazoles, compositions containing such compounds and methods of use |
| EP1863755A1 (en) | 2005-03-21 | 2007-12-12 | Merck & Co., Inc. | Substituted aryl and heteroaryl derivatives |
| JP2008534593A (en) | 2005-03-30 | 2008-08-28 | メルク エンド カムパニー インコーポレーテッド | Glucagon receptor antagonist compounds, compositions containing such compounds, and methods of use thereof |
| JP2009502923A (en) | 2005-07-26 | 2009-01-29 | メルク エンド カムパニー インコーポレーテッド | Method for the synthesis of substituted pyrazoles |
| TW200745031A (en) | 2005-10-13 | 2007-12-16 | Merck & Co Inc | Acyl indoles, compositions containing such compounds and methods of use |
| EP2001472A2 (en) | 2006-03-23 | 2008-12-17 | Merck and Co., Inc. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| JP2009537525A (en) | 2006-05-16 | 2009-10-29 | メルク エンド カムパニー インコーポレーテッド | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| TW200821284A (en) | 2006-10-03 | 2008-05-16 | Merck & Co Inc | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| BR112013016033A2 (en) | 2010-12-23 | 2018-06-05 | Pfizer | glucagon receptor modulators |
| ES2597972T3 (en) | 2011-02-08 | 2017-01-24 | Pfizer Inc | Glucagon receptor modulator |
| ES2550345T3 (en) | 2011-07-22 | 2015-11-06 | Pfizer Inc. | Quinolinylglucagon receptor modulators |
| US9649294B2 (en) | 2013-11-04 | 2017-05-16 | Merck Sharp & Dohme Corp. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0010651A (en) * | 1999-05-17 | 2002-03-19 | Novo Nordisk As | Compound, use of a compound, pharmaceutical composition, and method for the treatment and / or prevention of disorders or diseases mediated by an antagonistic action of glucagon |
-
2002
- 2002-12-12 WO PCT/DK2002/000847 patent/WO2003051357A1/en not_active Application Discontinuation
- 2002-12-12 AU AU2002351730A patent/AU2002351730A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003051357A1 (en) | 2003-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003233780A1 (en) | Novel glucagon antagonists/inverse agonists | |
| AU2002347022A1 (en) | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten | |
| AU2003236205A1 (en) | Glucagon antagonists/inverse agonists | |
| AU2003290700A1 (en) | Farnesoid x receptor agonists | |
| AU1772300A (en) | Glucagon antagonists/inverse agonists | |
| AU2002365622A1 (en) | Novel glucagon antagonists | |
| IL153181A0 (en) | Glucagon antagonists/inverse agonists | |
| AU2002223501A1 (en) | Glucagon antagonists/inverse agonists | |
| AU2001255798A1 (en) | Glucagon antagonists | |
| AUPR833401A0 (en) | G protein-coupled receptor antagonists | |
| AU2002367424A1 (en) | Androgen receptor antagonists | |
| AU2002366384A1 (en) | Insulin and igf-1 receptor agonists and antagonists | |
| AU2003228485A1 (en) | Farnesoid x-activated receptor agonists | |
| HUP0401437A3 (en) | Adenosine a3 receptor agonists | |
| AU2002223500A1 (en) | Glucagon antagonists/inverse agonists | |
| AU2002351730A1 (en) | Glucagon receptor antagonists/inverse agonists | |
| AU2001264657A1 (en) | Crf receptor antagonists | |
| AU2003255501A1 (en) | Cxcr4 receptor antagonists | |
| AU2002365655A1 (en) | 5-ht7 receptor antagonists | |
| AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
| AU2003248356A1 (en) | Beta3-adrenergic receptor agonists | |
| AU2002359524A1 (en) | P2x7 receptor antagonists | |
| AU2002223502A1 (en) | Glucagon antagonist/inverse agonist | |
| AU2001249573A1 (en) | Chemokine receptor antagonists | |
| AU2001263288A1 (en) | Crf receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |